Palmolase-P Tablets: Polmacoxib 2 mg and Paracetamol 325 mg

Pain accompanied by inflammation can interfere with movement, comfort, and everyday activities. Palmolase-P Tablets contain Polmacoxib 2 mg and Paracetamol 325 mg, combining an anti-inflammatory component with an established analgesic in a single tablet.

The formulation is intended for appropriate short-term management of acute mild-to-moderate painful inflammatory conditions when prescribed by a healthcare professional. Palmolase-P is supplied in 10 × 10 Alu/Alu packing with an MRP of ₹2,150.

💡 Did You Know?

Palmolase-P Tablets combine Polmacoxib 2 mg, a selective COX-2 inhibitor, with Paracetamol 325 mg, an established analgesic and antipyretic. This gives the formulation a dual approach to pain management.

Palmolase-P Information

The Two-Ingredient Advantage

Palmolase-P brings together two active ingredients with complementary roles in pain management:

• Polmacoxib 2 mg – A selective COX-2 inhibitor that acts on pathways associated with pain and inflammation.

• Paracetamol 325 mg – An analgesic and antipyretic that primarily relieves pain and reduces fever.

• Combination Therapy – The two ingredients provide complementary actions within a single tablet.

• Convenient Dosage Form – A tablet formulation allows convenient administration when prescribed.

The goal is not simply to combine ingredients, but to provide a formulation that can be used appropriately for short-term painful inflammatory conditions.

Where Can Palmolase-P Be Used?

The specific Polmacoxib 2 mg + Paracetamol 325 mg combination is intended for appropriate acute painful inflammatory conditions. Depending on the patient's condition, medical history, and clinical assessment, a healthcare professional may consider it for:

01 — Acute Inflammatory Pain
May be prescribed for acute mild-to-moderate painful inflammatory conditions where this combination is appropriate.

02 — Musculoskeletal Discomfort
May be considered when acute musculoskeletal pain is associated with an inflammatory component.

03 — Pain Associated with Inflammation
The combination can provide complementary analgesic and anti-inflammatory activity for appropriate painful inflammatory conditions.

04 — Selected Joint-Related Pain
Polmacoxib has been studied in osteoarthritis-related symptoms; however, treatment should be based on the individual patient's medical assessment.

Medical note: The appropriate use of Palmolase-P depends on the diagnosis and advice of a qualified healthcare professional.

What Happens After You Take It?

The formulation works through the complementary properties of its two components.

Polmacoxib → COX-2 pathway
Polmacoxib selectively inhibits COX-2, reducing prostaglandin production involved in pain and inflammation.

Paracetamol → Pain relief
Paracetamol primarily provides analgesic and antipyretic effects, supporting pain and fever management.

Together → Complementary action
The combination brings these activities together in one formulation, providing a practical option when the prescribed treatment requires both components.

In short, Palmolase-P Tablets use two different pharmacological approaches to support short-term symptom management.

How Should Palmolase-P Be Taken?

The dose should always be based on the healthcare professional's instructions and the patient's individual circumstances.

For the referenced Polmacoxib 2 mg + Paracetamol 325 mg combination, prescribing information recommends:

Recommended regimen: 1 tablet once daily, unless otherwise directed by the physician.

Keep these points in mind:

• Follow the prescribed dose rather than adjusting it yourself.

• Do not take extra tablets to obtain faster pain relief.

• Check other medicines for Paracetamol before taking them alongside Palmolase-P.

• Use the combination for the duration recommended by your doctor.

⚠️ Never exceed the recommended dose. Excessive Paracetamol can cause serious liver damage.

Responsible dosing matters just as much as choosing the appropriate formulation.

What Side Effects Should You Know?

Most medicines can cause unwanted effects in some people. With this combination, gastrointestinal symptoms and other reactions may occur.

Common Reactions

Serious or Rare Reactions

If unusual or severe symptoms occur, seek medical attention promptly.

Before You Take Palmolase-P, Check These Points

A quick medical-history check can help reduce avoidable risks.

• Heart health: Tell your doctor about cardiovascular disease, hypertension, or cardiovascular risk factors.

• Kidney function: Patients with kidney problems should seek professional advice before use.

• Liver health: Inform your doctor about existing liver disease or other liver-related concerns.

• Stomach history: Previous ulcers or gastrointestinal bleeding should be discussed with your healthcare professional.

• Other medicines: Tell your doctor about other NSAIDs, Paracetamol products, anticoagulants, aspirin, corticosteroids or other regular medicines.

• Pregnancy or breastfeeding: Consult your healthcare professional before using Polmacoxib-containing medicines.

Your medical history matters. Never assume that a medicine suitable for one person is automatically suitable for another.

Palmolase-P: A Combination Built for Your Pharma Range

For pharmaceutical businesses looking to expand their product portfolio, Monark Biocare provides opportunities across different areas of the pharmaceutical sector. Businesses can explore PCD Pharma Franchise, third-party pharmaceutical manufacturing, ethical promotion, export medicines, and other pharmaceutical business solutions.

Whether the requirement involves developing a wider pharmaceutical product range, exploring manufacturing opportunities, or entering new markets, choosing the right pharmaceutical partner is an important part of long-term business planning.

Explore More with Monark Biocare

PCD Pharma Franchise — Explore pharmaceutical franchise opportunities with a diversified product portfolio.

Third-Party Manufacturing — Develop pharmaceutical products through professional contract manufacturing solutions.

Ethical Promotion — Support responsible pharmaceutical product promotion and market development.

Export Medicines — Explore opportunities for supplying pharmaceutical products to eligible international markets.

Monark Biocare
Plot No. 201, HSIIDC, Alipur, Barwala, Haryana, India
Email: monarkbiocare@gmail.com
Phone: +91-9855986633 | +91-9023256719 | +91-9888656719

Frequently Asked Questions About Palmolase-P

01. What is Palmolase-P Tablet?

Palmolase-P Tablet is a combination formulation containing Polmacoxib 2 mg and Paracetamol 325 mg, intended for appropriate short-term management of acute mild-to-moderate painful inflammatory conditions under medical supervision.

02. What is the composition of Polmacoxib 2 mg and Paracetamol 325 mg Tablets?

Each Palmolase-P tablet contains Polmacoxib 2 mg + Paracetamol 325 mg.

03. What is the usual dosage of Palmolase-P?

For the referenced 2 mg/325 mg combination, prescribing information recommends one tablet once daily. The patient's doctor should determine the appropriate dosage and duration.

04. Can Palmolase-P be taken with other Paracetamol medicines?

Do not take additional Paracetamol-containing medicines without medical advice. Combining products can unintentionally increase total Paracetamol intake.

05. Who should consult a doctor before using Palmolase-P?

People with heart, kidney, liver, or gastrointestinal problems, those taking interacting medicines, and women who are pregnant or breastfeeding should seek professional medical advice before using the product.

Important Disclaimer

This information is intended for general educational and product-information purposes only. Palmolase-P Tablets should be used only under the guidance of a qualified healthcare professional. Dosage, duration, suitability, contraindications and interactions can vary between individuals. Do not self-medicate or exceed the recommended dose.